a-CTLA4-TGFβRII was far more effective than a-CTLA-4 in counteracting Treg-mediated suppression and restoring activation of tumor antigen-specific T cells in the presence of autologous Tregs (Fig. 3d). This evidence concerns the gene CTLA4 and neoplasm.